GOLIVER THERAPEUTICS
GoLiver Therapeutics is a spin-off of Inserm and the University of Nantes (CRTI UMR1064, ITUN, University Hospital of Nantes), specializing in the development of Innovative Therapy Drugs (MTI) to meet an urgent medical need not met in transplantation.
GOLIVER THERAPEUTICS
Industry:
Biotechnology
Founded:
2017-01-01
Address:
Nantes, Pays De La Loire, France
Country:
France
Website Url:
http://www.golivertx.com
Total Employee:
1+
Status:
Active
Contact:
33 (0) 782721251
Email Addresses:
[email protected]
Total Funding:
1000 K EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Memo Therapeutics
Memo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Current Employees Featured
Investors List
Government of France
Government of France investment in Grant - GoLiver Therapeutics
Official Site Inspections
http://www.golivertx.com
- Host name: 195-15-253-80.dc3-a.pub1.etik-cloud.com
- IP address: 195.15.253.80
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
